Stock 9966 ALPHAMAB ONCOLOGY
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Alphamab Oncology

Equities

9966

KYG0330A1013

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 am EDT 		5-day change 1st Jan Change
2.54 HKD +4.53% Intraday chart for Alphamab Oncology -45.61% -61.75%
May. 29 Hong Kong Stocks Close Lower Following Mixed Session on Wall Street MT
May. 29 Alphamab's Phase 3 Trial for Pancreatic Cancer Treatment Fails to Reach Preset Statistical Endpoint; Shares Plunge 38% MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alphamab Oncology Resignation of Xu Zhan Kevin as Non-Executive Director and Member of the Strategy Committee
CI
HBM Holdings Names CFO/Chief Business Officer
MT
Alphamab Oncology Announces Board and Committee Changes
CI
Alphamab Oncology Hires Former Junshi Bio Marketing Head as Commercial Chief; Shares Jump 3%
MT
Alphamab Oncology Announces Appointment of HAN Jing as Chief Commercial Officer
CI
Alphamab Oncology Announces Board Changes
CI
Alphamab Oncology : CASI Pharmaceuticals Chief Financial Officer Moves to Alphamab Oncology
MT
Alphamab Oncology Appoints Johannes Nippgen as its Chief Medical Officer
CI
Alphamab Oncology Appoints Xu Weihao as Chief Financial Officer
CI
Alphamab Oncology Announces Executive Changes
CI
Alphamab Oncology Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 9966 Stock
  4. News Alphamab Oncology
  5. Insiders